Novartis International AG, Wed, October 29, 2008 03:00pm CET

MEDIA RELEASE

Rasilez HCT®, single pill combination of Rasilez® and diuretic, receives Swiss approval for the treatment of high blood pressure

Rasilez HCT® (aliskiren and hydrochlorothiazide), a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez®[*] (aliskiren) and the diuretic hydrochlorothiazide (HCT) - has been approved by Swissmedic as a new treatment for high blood pressure. High blood pressure is ...more

Nycomed, Tue, October 28, 2008 09:00am CET

PRESS RELEASE

Nycomed’s Daxas® shows encouraging preliminary results in phase III COPD studies

Nycomed today announced encouraging results from a preliminary analysis of four Phase III trials of Daxas® (roflumilast) in the treatment of symptomatic COPD. Two pivotal 12-month studies met their primary endpoints, showing effects on exacerbation rates and pulmonary function (FEV1). Furthermore, two supporting six-month ...more

Eurotransplant, Tue, September 23, 2008 03:00pm CET

PRESS RELEASE

Organ donation is decreasing!

Eurotransplant is concerned about the drop in organ donation that is seen since the beginning of this year. The 4% drop in the 7 Eurotransplant member countries leads to increased waiting times for transplant patients. The reduction in donated organs was most pronounced in kidney transplants where the decrease was 6,5% ...more

AxiCorp GmbH, Mon, September 08, 2008 03:00pm CET

FOR IMMEDIATE RELEASE

Biocon Limited presents human clinical data on IN-105 (oral insulin) at the EASD meeting in Rome

The results indicate that IN-105 is safe and well tolerated by Type 2 diabetic patients and is able to significantly drop 2-hour post prandial glucose in a dose-related manner. Biocon Limited, India’s premier biotechnology company, announced the results of an ascending dose study with their oral insulin drug (IN-105) at ...more

APOTHEKE ADHOC, Tue, August 26, 2008 09:00am CET

PHARMACIES IN THE SIGHT OF THE EU

SHOWDOWN IN LUXEMBOURG - The new dossier from APOTHEKE ADHOC

On 3 September, the European Court of Justice will review the German and Italian pharmacy laws. The restrictions on ownership and establishment of several EU Member States are challenged by the EU. The European Commission has launched infringement proceedings against Austria, Bulgaria, France, Germany, Italy, Portugal and ...more

Pages: 1